TANATRIL

This brand name is authorized in Austria, Hong Kong, Japan, Poland, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug TANATRIL contains one active pharmaceutical ingredient (API):

1 Imidapril UNII 7NSF9GG1NU - IMIDAPRIL HYDROCHLORIDE

The hypotensive effect of imidapril in hypertension appears to result primarily from the suppression of the plasma renin-angiotensin-aldosterone system. Read about Imidapril

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TANATRIL Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09AA16	Imidapril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13984, 146233, 162626, 21798, 21861
Country: HK	Department of Health Drug Office	Identifier(s): 51393, 51394
Country: JP	医薬品医療機器総合機構	Identifier(s): 2144008F1021, 2144008F2028, 2144008F3024
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100124207, 100124220, 100124236
Country: SG	Health Sciences Authority	Identifier(s): 10614P, 10615P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6653463, 6653464
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699543010465, 8699543010472, 8699543010489, 8699543010496, 8699543010502, 8699543010519, 8699543010793, 8699543010809, 8699543010816